We are very proud to announce that Biodentine, the first all-in-one biocompatible and bioactive dentin substitute, counts more than 700 publications on Pubmed!

Since the outbreak of the coronavirus pandemic, immediate measures have been taken to protect the health and well-being of our employees and partners at the various Septodont sites around the world, including our manufacturing facilities and headquarters, to help ensure dental practitioners around the globe will continuously receive our dental solutions with the best possible service and support.

At Septodont, we foster an inclusive environment and promote equal opportunities for people with disabilities.

Following the ESE (European Society of Endodontology) position statement for managing the exposed pulp, supported by 3 clinical studies run over the past 3 years showing 95% clinical success

At Septodont, we work every day to build a world free of dental pain thanks to our global approach to pain management before, during, and after your procedures.